What is KeyCorp's Forecast for Corteva FY2029 Earnings?

Key Points

• KeyCorp forecasts Corteva’s FY2029 EPS at $1.60 and maintains an “Overweight” rating with a $17 price target, below the current full-year consensus estimate of $2.77 per share.
• Analyst sentiment is broadly positive: 16 analysts rate Corteva a Buy, six a Hold and one a Sell, producing a consensus “Moderate Buy” rating.
• Corteva’s latest quarterly EPS of $2.30 exceeded expectations of $2.24, while revenue declined 1.2% year over year; the company also pays a quarterly dividend of $0.18 per share, or a 4.9% annualized yield.

Corteva, Inc. (NYSE:CTVA - Free Report) - Investment analysts at KeyCorp issued their FY2029 EPS estimates for shares of Corteva in a research report issued to clients and investors on Wednesday, October 7th. KeyCorp analyst S. Tiano forecasts that the company will earn $1.60 per share for the year. KeyCorp currently has a "Overweight" rating and a $17.00 target price on the stock. The consensus estimate for Corteva's current full-year earnings is $2.77 per share.

A number of other research analysts have also recently weighed in on the company. UBS Group raised their price target on Corteva from $85.00 to $90.00 and gave the company a "neutral" rating in a research report on Wednesday, September 16th. Bank of America raised their target price on shares of Corteva from $90.00 to $96.00 and gave the company a "buy" rating in a report on Monday, July 20th. Royal Bank Of Canada restated an "outperform" rating and set a $17.00 target price on shares of Corteva in a research report on Wednesday. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a $101.00 price target on shares of Corteva in a research report on Monday, August 3rd. Finally, Oppenheimer set a $17.00 price objective on shares of Corteva in a research note on Monday. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Corteva presently has an average rating of "Moderate Buy" and a consensus target price of $64.00.

Corteva Stock Performance

NYSE CTVA opened at $14.56 on Thursday. The business has a 50 day moving average price of $74.30 and a 200 day moving average price of $79.19. The company has a market capitalization of $9.72 billion, a P/E ratio of 9.64, a PEG ratio of 0.73 and a beta of 0.57. Corteva has a 1-year low of $11.74 and a 1-year high of $90.97. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10.

Corteva (NYSE:CTVA - Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 EPS for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm had revenue of $6.38 billion during the quarter, compared to analysts' expectations of $6.60 billion. During the same quarter last year, the business earned $2.20 earnings per share. The business's revenue for the quarter was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st were paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 4.9%. The ex-dividend date of this dividend was Tuesday, September 1st. Corteva's dividend payout ratio (DPR) is currently 47.68%.

Hedge Funds Weigh In On Corteva

A number of institutional investors have recently modified their holdings of the company. EFG International AG acquired a new stake in Corteva during the second quarter worth approximately $25,000. Compass Financial Management LLC acquired a new position in Corteva in the 2nd quarter valued at $25,000. Cornerstone Financial Management LLC purchased a new position in shares of Corteva during the 4th quarter worth $29,000. Elevation Wealth Partners LLC lifted its stake in shares of Corteva by 334.6% during the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company's stock worth $29,000 after purchasing an additional 261 shares during the period. Finally, Clearstead Trust LLC acquired a new stake in shares of Corteva during the second quarter worth $31,000. Institutional investors and hedge funds own 81.54% of the company's stock.

Corteva News Roundup

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: KeyBanc upgraded Corteva to Overweight after the Vylor spinoff, citing potential for “meaningful” earnings growth after 2027 and a more focused crop-protection business. Corteva Could See Meaningful Earnings Growth After 2027, KeyBanc Says in Upgrade
• Positive Sentiment: JPMorgan raised Corteva to Overweight with a $19 price target, implying substantial upside from the referenced $14.56 price. The bank characterized the shares as undervalued following the Vylor separation, helping drive a recent rally. JPMorgan Upgrades Corteva to Overweight
• Positive Sentiment: Options activity was unusually bullish, with investors purchasing 5,408 call options—about 532% above typical daily call volume—signaling increased speculative interest in a further recovery.
• Neutral Sentiment: Jim Cramer said he favors Vylor, the spun-off seed company, while remaining cautious on Corteva’s crop-protection operations. The comments highlight both the potential value unlocked by the breakup and concerns about Corteva’s remaining business. Jim Cramer Sees One Stock to Own After Corteva’s Breakup
• Neutral Sentiment: Corteva will report third-quarter 2026 results after the market closes on November 11, with a webcast scheduled for November 12. The announcement provides a future catalyst but does not change current fundamentals. Corteva Announces Third-Quarter Earnings Date
• Negative Sentiment: Zacks Research downgraded Corteva from “Hold” to “Strong Sell.” This is the newest company-specific development and may be weighing on the shares, particularly after the recent analyst-driven increase. Corteva Downgraded by Zacks Research to Strong Sell

About Corteva

Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.

The company's seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.

Corteva serves farmers, agricultural retailers and other customers in markets around the world.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.